Zhejiang Xianju Pharmaceutical Co Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Xianju Pharmaceutical Co Limited with three other
companies in this sector in China:
Cisen Pharmaceutical Co Ltd
sales of 2.96 billion Chinese Renmimbi [US$431.73 million]
of which 97%
was Pharmaceutical manufacture),
Chengdu Kanghong Pharmaceutical Group Co Ltd
(2.79 billion Chinese Renmimbi [US$406.08 million]
of which 100%
was Pharmaceutical Manufacturing), and
Sihuan Pharmaceutical Holdings Group Ltd
(2.75 billion Chinese Renmimbi [US$400.15 million]
of which 100%
was Pharmaceutical Prods).
Zhejiang Xianju Pharmaceutical Co Limited reported sales of 2.85 billion Chinese Renmimbi (US$415.70 million)
December of 2017.
increase of 13.9%
versus 2016, when the company's sales were 2.50 billion Chinese Renmimbi.
Sales at Zhejiang Xianju Pharmaceutical Co Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 43%).
Sales of Medicine saw an increase
14.2% in 2017, from
2.49 billion Chinese Renmimbi to 2.85 billion Chinese Renmimbi.
Not all segments of Zhejiang Xianju Pharmaceutical Co Limited experienced an increase in sales in 2017:
sales of Others fell 41.5% to 6.58 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).